A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression

Journal of Affective Disorders

Volumn 128, Issue 1-2, 2011, Pages 56-63

  Serretti, Alessandro ^a   Chiesa, Alberto ^a   Calati, Raffaella ^a   Massat, Isabelle ^h   Linotte, Sylvie ^b   Kasper, Siegfried ^e   Lecrubier, Yves ^f   Antonijevic, Irina ^d   Forray, Carlos ^d   Snyder, Lenore ^d   Bollen, Joseph ^c   Zohar, Joseph ^g   De Ronchi, Diana ^a   Souery, Daniel ^b   Mendlewicz, Julien ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c Watering van Sint Truiden   (Belgium)

^d LUNDBECK RESEARCH USA   (United States)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g SHEBA MEDICAL CENTER   (Israel)

^h FNRS   (Belgium)

Author keywords

CREB1; Major depression; Remission; Response; Treatment resistance

Indexed keywords

CITALOPRAM; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MILNACIPRAN; MIRTAZAPINE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PREDICTION; PRIORITY JOURNAL; REMISSION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; ALLELES; ANTIDEPRESSIVE AGENTS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; REMISSION INDUCTION; RISK FACTORS; SAMPLING STUDIES; TREATMENT OUTCOME;

EID: 78649655526     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2010.06.025     Document Type: Article

References (50)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th Edition 1994 American Psychiatric Association Washington DC
2. J. Angst The prognosis of antidepressive treatments: longitudinal and genetic studies Anglo Ger. Med. Rev. 2 1965 733 751
3. J.C. Barrett, B. Fry, J. Maller, and M.J. Daly Haploview: analysis and visualization of LD and haplotype maps Bioinformatics 21 2005 263 265
4. R.H. Belmaker, and G. Agam Major depressive disorder N. Engl J. Med. 358 2008 55 68
5. J.A. Blendy The role of CREB in depression and antidepressant treatment Biol. Psychiatry 59 2006 1144 1150
6. I. Burcescu, K. Wigg, N. King, A. Vetro, E. Kiss, L. Katay, J.L. Kennedy, M. Kovacs, and C.L. Barr Association study of CREB1 and childhood-onset mood disorders Am. J. Med. Genet. B Neuropsychiatr. Genet. 137B 2005 45 50
7. S. Campbell, and G. Macqueen The role of the hippocampus in the pathophysiology of major depression J. Psychiatry Neurosci. 29 2004 417 426
8. J. Cohen Statistical Power Analysis for the Behavioral Sciences 1988 Lawrence Erlbaum Associates Hillsdale, New Jersey
9. D. Dowlatshahi, G.M. MacQueen, J.F. Wang, and L.T. Young Increased temporal cortex CREB concentrations and antidepressant treatment in major depression Lancet 352 1998 1754 1755
10. Y. Dwivedi, J.S. Rao, H.S. Rizavi, J. Kotowski, R.R. Conley, R.C. Roberts, C.A. Tamminga, and G.N. Pandey Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects Arch. Gen. Psychiatry 60 2003 273 282
11. J.R. Geddes, N. Freemantle, J. Mason, M.P. Eccles, and J. Boynton SSRIs versus other antidepressants for depressive disorder Cochrane Database Syst. Rev. 2000 CD001851
12. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
13. C. Hercher, G. Turecki, and N. Mechawar Through the looking glass: examining neuroanatomical evidence for cellular alterations in major depression J. Psychiatr. Res. 43 2009 947 961
14. J.M. Hettema, S.S. An, E.J. van den Oord, M.C. Neale, K.S. Kendler, and X. Chen Association study of CREB1 with major depressive disorder and related phenotypes Am. J. Med. Genet. B Neuropsychiatr. Genet. 8 2009 1128 1132
15. M. Kato, and A. Serretti Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder Mol. Psychiatry 15 2008 473 500
16. R.C. Kessler, P. Berglund, and O. Demler The epidemiology of major depressive disorder: results from the national comorbidiy survey replication (NCS-R) JAMA 289 2003 3095 3105
17. J.M. Koch, S. Kell, D. Hinze-Selch, and J.B. Aldenhoff Changes in CREB-phosphorylation during recovery from major depression J. Psychiatr. Res. 36 2002 369
18. B.S. Maher, H.B. Hughes III, W.N. Zubenko, and G.S. Zubenko Genetic linkage of region containing the CREB1 gene to depressive disorders in families with recurrent, early-onset, major depression: a re-analysis and confirmation of sex-specific effect Am. J. Med. Genet. B Neuropsychiatr. Genet. 5 2009 10 16
19. A.K. Malhotra, G.M. Murphy Jr., and J.L. Kennedy Pharmacogenetics of psychotropic drug response Am. J. Psychiatry 161 2004 780 796
20. F. Mamdani, M. Alda, P. Grof, L.T. Young, G. Rouleau, and G. Turecki Lithium response and genetic variation in the CREB family of genes Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B 2008 500 504
21. B. Mayr, and M. Montminy Transcriptional regulation by the phosphorylation-dependent factor CREB Nat. Rev. Mol. Cell Biol. 2 2001 599 609
22. Y. Odagaki, J.A. Garcia-Sevilla, P. Huguelet, R. La Harpe, T. Koyama, and J. Guimon Cyclic AMP-mediated signaling components are upregulated in the prefrontal cortex of depressed suicide victims Brain Res. 898 2001 224 231
23. A. Orsini Antidepressant responses and segregation analyses in affective families G. Racagni, E. Smeraldi, Anxious Depression: assessment and treatment 1987 Raven Press New York
24. C.M. Pare, L. Rees, and M.J. Sainsbury Differentiation of two genetically specific types of depression by the response to anti-depressants Lancet 2 1962 1340 1343
25. R.H. Perlis, S. Purcell, J. Fagerness, C. Cusin, L. Yamaki, M. Fava, and J.W. Smoller Clinical and genetic dissection of anger expression and CREB1 polymorphisms in major depressive disorder Biol. Psychiatry 62 2007 536 540
26. R.H. Perlis, S. Purcell, M. Fava, J. Fagerness, A.J. Rush, M.H. Trivedi, and J.W. Smoller Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study Arch. Gen. Psychiatry 64 2007 689 697
27. R. Philibert, K. Caspers, D. Langbehn, E.P. Troughton, R. Yucuis, H.K. Sandhu, and R.J. Cadoret The association of the D2S2944 124 bp allele with recurrent early onset major depressive disorder in women Am. J. Med. Genet. B Neuropsychiatr. Genet. 121B 2003 39 43
28. R.J. Porter, C. Bourke, and P. Gallagher Neuropsychological impairment in major depression: its nature, origin and clinical significance Aust. NZ J. Psychiatry 41 2007 115 128
29. M.A. Posternak, and M. Zimmerman How accurate are patients in reporting their antidepressant treatment history? J. Affect. Disord. 75 2003 115 124
30. A.J. Rush, M.H. Trivedi, S.R. Wisniewski, A.A. Nierenberg, J.W. Stewart, D. Warden, G. Niederehe, M.E. Thase, P.W. Lavori, B.D. Lebowitz, P.J. McGrath, J.F. Rosenbaum, H.A. Sackeim, D.J. Kupfer, J. Luther, and M. Fava Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report Am. J. Psychiatry 163 2006 1905 1917
31. A. Serretti, L. Franchini, M. Gasperini, R. Rampoldi, and E. Smeraldi Mode of inheritance in mood disorders families according to fluvoxamine response Acta Psychiatr. Scand. 98 1998 443 450
32. A. Serretti, R. Calati, I. Massat, S. Linotte, S. Kasper, Y. Lecrubier, R. Sens-Espel, J. Bollen, J. Zohar, J. Berlo, P. Lienard, D. De Ronchi, J. Mendlewicz, and D. Souery Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients Int. Clin. Psychopharmacol. 24 2009 250 256
33. D. Souery, P. Oswald, I. Massat, U. Bailer, J. Bollen, K. Demyttenaere, S. Kasper, Y. Lecrubier, S. Montgomery, A. Serretti, J. Zohar, and J. Mendlewicz Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study J. Clin. Psychiatry 68 2007 1062 1070
34. StatSoft, I., 1995. STATISTICA per Windows. StatSoft Italia srl.
35. P.F. Sullivan Spurious genetic associations Biol. Psychiatry 61 2007 1121 1126
36. P.F. Sullivan, M.C. Neale, and K.S. Kendler Genetic epidemiology of major depression: review and meta-analysis Am. J. Psychiatry 157 2000 1552 1562
37. F. Sulser The role of CREB and other transcription factors in the pharmacotherapy and etiology of depression Ann. Med. 34 2002 348 356
38. A.K. Taylor, I. Klisak, T. Mohandas, R.S. Sparkes, C. Li, R. Gaynor, and A.J. Lusis Assignment of the human gene for CREB1 to chromosome 2q32.3-q34 Genomics 7 1990 416 421
39. S. Utge, P. Soronen, T. Partonen, A. Loukola, E. Kronholm, S. Pirkola, E. Nyman, T. Porkka-Heiskanen, and T. Paunio A population-based association study of candidate genes for depression and sleep disturbance Am. J. Med. Genet. B Neuropsychiatr. Genet. 153 2009 468 476
40. E.J. Weeber, and J.D. Sweatt Molecular biology of human cognition Neuron 33 2002 845 848
41. M.J. Wilkie, D. Smith, I.C. Reid, R.K. Day, K. Matthews, C.R. Wolf, D. Blackwood, and G. Smith A splice site polymorphism in the G-protein beta subunit influences antidepressant efficacy in depression Pharmacogenet. Genomics 17 2007 207 215
42. World Health Organization Impact of disorders http://www.who.int/whr/ 2001/chapter2/en/index3.html 2001
43. World Health Organization The world health report 2002-reducing risks, promoting healthy life 2002 Geneva
44. S. Yamada, M. Yamamoto, H. Ozawa, P. Riederer, and T. Saito Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder J. Neural Transm. 110 2003 671 680
45. L.T. Young, Y.B. Bezchlibnyk, B. Chen, J.F. Wang, and G.M. MacQueen Amygdala cyclic adenosine monophosphate response element binding protein phosphorylation in patients with mood disorders: effects of diagnosis, suicide, and drug treatment Biol. Psychiatry 55 2004 570 577
46. G.S. Zubenko, and H.B. Hughes III Effects of the G(- 656)A variant on CREB1 promoter activity in a glial cell line: interactions with gonadal steroids and stress Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B 2008 579 585
47. G.S. Zubenko, and H.B. Hughes III Effects of the G(- 656)A variant on CREB1 promoter activity in a neuronal cell line: interactions with gonadal steroids and stress Mol. Psychiatry 14 2009 390 397
48. G.S. Zubenko, H.B. Hughes, J.S. Stiffler, W.N. Zubenko, and B.B. Kaplan Genome survey for susceptibility loci for recurrent, early-onset major depression: results at 10 cM resolution Am. J. Med. Genet. 114 2002 413 422
49. G.S. Zubenko, I.H. Hughes, J.S. Stiffler, W.N. Zubenko, and B.B. Kaplan D2S2944 identifies a likely susceptibility locus for recurrent, early-onset, major depression in women Mol. Psychiatry 7 2002 460 467
50. G.S. Zubenko, H.B. Hughes III, J.S. Stiffler, A. Brechbiel, W.N. Zubenko, B.S. Maher, and M.L. Marazita Sequence variations in CREB1 cosegregate with depressive disorders in women Mol. Psychiatry 8 2003 611 618